Technological and biological evaluation of tablets containing different strains of lactobacilli for vaginal administration.

Ten strains of lactobacilli were evaluated for the administration of viable microorganisms to restore the normal indigenous flora in the treatment of urogenital tract infections (UTI) in women. As the strains considered are facultative anaerobes, optimization of the production process was particularly critical to preserve bacterial viability. The microorganisms were formulated in single- and double-layer vaginal tablets. The two layers were characterized by different release properties: one is an effervescent composition that ensures a rapid and complete distribution of the active ingredient over the whole vaginal surface; while the second is a sustained release composition capable of releasing the lactobacilli over a longer period of time. Three different retarding polymers were tested, and all the formulations and tablets were evaluated in terms of technological processability, bacterial viability and stability, and cell adhesion properties of the microorganisms. From the results obtained, three out of ten strains appear particularly suitable for their application in the treatment of UTI. A larger batch of tablets made with a mixture of the three strains was then evaluated, confirming the feasibility of their industrial production and a good bacterial viability in the final dosage form.

[1]  A. Bruce,et al.  Prevention of urinary tract infection in rats with an indigenous Lactobacillus casei strain , 1985, Infection and immunity.

[2]  G. Reid,et al.  Vaginal flora and urinary tract infections , 1991 .

[3]  J. Sobel,et al.  Adherence of bacteria to vaginal epithelial cells at various times in the menstrual cycle , 1981, Infection and immunity.

[4]  C. Surawicz,et al.  Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. , 1996, JAMA.

[5]  S. Hillier,et al.  Microbiologic Characteristics of Lactobacillus Products Used for Colonization of the Vagina , 1990, Obstetrics and gynecology.

[6]  I. Phillips,et al.  ANAEROBIC VAGINOSIS (NON-SPECIFIC VAGINITIS): CLINICAL, MICROBIOLOGICAL, AND THERAPEUTIC FINDINGS , 1983, The Lancet.

[7]  A. Bruce,et al.  Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infections. , 1988, Canadian journal of microbiology.

[8]  B. Drasar,et al.  Recent Advances in Anaerobic Bacteriology , 1987, New Perspectives in Clinical Microbiology.

[9]  P. Mårdh,et al.  Adherence of bacterial to vaginal epithelial cells , 1976, Infection and immunity.

[10]  M. Wilks,et al.  The Anaerobic Bacterial Flora of the Vagina in Health and Disease , 1987 .

[11]  M A Krohn,et al.  The normal vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  J. Costerton,et al.  The human vagina: normal flora considered as an in situ tissue-associated, adherent biofilm. , 1991, Genitourinary medicine.

[13]  M. Krohn,et al.  The relationship of hydrogen peroxide‐producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women , 1992, Obstetrics and gynecology.

[14]  P. Brigidi,et al.  Pharmaceutical formulations for the vaginal administration of viable microorganisms , 1994 .

[15]  A. Servin,et al.  Adhesion of human Lactobacillus acidophilus strain LB to human enterocyte-like Caco-2 cells. , 1992, Journal of general microbiology.

[16]  S. Hillier,et al.  Control of the microbial flora of the vagina by H2O2-generating lactobacilli. , 1991, The Journal of infectious diseases.

[17]  A. Bruce,et al.  Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract. , 1987, The Journal of urology.